Prestige Brand Holdings (PBH) Stock Price, Quote & News

Company Profile

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name;...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 914 524 6800

Website: www.prestigebrands.com

Address:

660 White Plains Road, Tarrytown, United States

StocktwitsEarnings May. 13 at 8:45 PM

$PBH Q4 '26 Earnings Results & Recap • Reported GAAP EPS of $1.14 up 12.87% YoY • Reported revenue of $281.62M down -5.03% YoY • Prestige Consumer Healthcare Inc. anticipates fiscal 2027 organic revenue growth of 1.0% to 3.0% and adjusted diluted EPS of $4.42 to $4.51, with free cash flow expected to be $250 million or more.

0 · Reply

Estimize Apr. 28 at 1:00 PM

Wall St is expecting 1.39 EPS for $PBH Q4 [Reporting 04/30 BMO] http://www.estimize.com/intro/pbh?chart=historical&metric_name=eps&utm_cont

0 · Reply

Estimize Apr. 21 at 1:00 PM

Wall St is expecting 1.39 EPS for $PBH Q4 [Reporting 04/30 BMO] http://www.estimize.com/intro/pbh?chart=historical&metric_name=eps&utm_cont

0 · Reply

SuperGreenToday Apr. 7 at 2:19 AM

$PBH Share Price: $55.13 Contract Selected: Oct 16, 2026 $45 Calls Buy Zone: $7.65 – $9.45 Target Zone: $12.57 – $15.37 Potential Upside: 55% ROI Time to Expiration: 192 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

PickAlpha Mar. 20 at 3:44 PM

3/6: Prestige Consumer signs definitive agreement to buy Breathe Right and related OTC assets for $1.045 bn in cash. | View: The sizeable $1.045 billion cash acquisition could be value-creating… $PBH $XLP $PG $CL

0 · Reply

OfficialStocktwitsUser Mar. 11 at 4:05 AM

$PBH RSI: 45.06, MACD: 0.3794 Vol: 1.52, MA20: 67.89, MA50: 65.83 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

ZacksResearch Feb. 12 at 3:20 PM

$PBH Q3 earnings miss & revenue beat — what's the impact? 🤔 EPS fell short of the Zacks Consensus Estimate, while revenues managed to top expectations despite a year-over-year decline due to Clear Eyes supply constraints. 📉 The company's fiscal 2026 sales outlook narrows as consumer headwinds persist, affecting order patterns across various channels. Full breakdown here 👉 https://www.zacks.com/stock/news/2861914/pbhs-q3-earnings-miss-estimates-revenues-surpass-stock-up?cid=sm-stocktwits-2-2861914-body-33278&ADID=SYND_STOCKTWITS_TWEET_2_2861914_BODY_33278

0 · Reply

ZacksResearch Feb. 12 at 2:20 PM

$PBH Q3 mixed bag — but the market’s cheering anyway 👀 Earnings missed estimates, revenues came in ahead, and the stock is up. That tells you where sentiment is leaning right now — top-line strength is winning the narrative. Is this momentum sustainable or just a relief pop? Full breakdown here 👉 https://www.zacks.com/stock/news/2861914/pbhs-q3-earnings-miss-estimates-revenues-surpass-stock-up?cid=sm-stocktwits-2-2861914-teaser-33258&ADID=SYND_STOCKTWITS_TWEET_2_2861914_TEASER_33258

0 · Reply

briefingcom Feb. 5 at 1:39 PM

$PBH: Prestige Consumer reports EPS in-line, revs in-line; guides FY26 EPS below consensus, revs below consensus https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20260205060632PBH&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

0 · Reply

StocktwitsEarnings Feb. 5 at 11:13 AM

$PBH Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $0.98 down -20.33% YoY • Reported revenue of $283.44M down -2.37% YoY

0 · Reply

Prestige Consumer Healthcare Inc. Reports Fiscal 2026 Results, Announces Acquisition of LaCorium Health

2026-05-07T14:39:47.000Z - 6 days ago

Prestige Consumer price target lowered to $65 from $77 at Oppenheimer

Apr 30, 2026, 8:00 AM EDT - 13 days ago

Prestige Consumer Healthcare to Release Fiscal 2026 Fourth Quarter and Year-End Earnings Results

Mar 20, 2026, 1:34 PM EDT - 7 weeks ago

Prestige Consumer Healthcare to Buy Breathe Right, Other Brands for $1.045 Billion

Mar 20, 2026, 8:30 AM EDT - 7 weeks ago

Prestige Consumer Healthcare Transcript: M&A announcement

2026-03-20T10:27:40.000Z - 7 weeks ago

Prestige Consumer to acquire Breathe Right, other brands for $1.045B

Mar 20, 2026, 6:15 AM EDT - 7 weeks ago

Prestige Consumer Healthcare Announces Agreement to Acquire Breathe Right®, the Leader in Nasal Strips

2026-02-06T11:40:27.000Z - 3 months ago

Prestige Consumer price target lowered to $86 from $88 at Canaccord

Feb 5, 2026, 8:30 AM EST - 3 months ago

Prestige Consumer Healthcare Earnings Call Transcript: Q3 2026

Feb 5, 2026, 6:00 AM EST - 3 months ago

Prestige Consumer Healthcare Inc. Reports Third Quarter and Year-to-Date Fiscal 2026 Results

2026-01-30T17:50:16.000Z - 3 months ago

Prestige Consumer price target lowered to $66 from $70 at Jefferies

Jan 13, 2026, 9:30 AM EST - 4 months ago

Prestige Consumer Healthcare Transcript: 28th Annual Needham Growth Conference Virtual

Jan 12, 2026, 8:00 AM EST - 4 months ago

Prestige Consumer Healthcare Announces Fiscal 2026 Third Quarter Earnings Results Date and Participation in the ICR Conference

2025-11-07T12:01:03.000Z - 6 months ago

Prestige Consumer price target lowered to $88 from $100 at Canaccord

Nov 6, 2025, 8:30 AM EST - 6 months ago

Prestige Consumer Healthcare Earnings Call Transcript: Q2 2026

Nov 6, 2025, 6:00 AM EST - 6 months ago

Prestige Consumer Healthcare Inc. Reports Second Quarter and First Half Fiscal 2026 Results

2025-10-27T11:46:46.000Z - 7 months ago

Prestige Consumer price target lowered to $71 from $75 at Jefferies

2025-10-21T11:55:32.000Z - 7 months ago

Prestige Consumer price target lowered to $72 from $82 at Oppenheimer

Oct 6, 2025, 5:00 PM EDT - 7 months ago

Prestige Consumer Healthcare to Release Fiscal 2026 Second Quarter Earnings Results

2025-09-24T11:30:23.000Z - 8 months ago

Prestige Consumer upgraded to Buy from Neutral at Sidoti

Sep 18, 2025, 3:15 PM EDT - 8 months ago

Prestige Consumer Healthcare Transcript: Small-Cap Virtual Conference

Sep 4, 2025, 12:45 PM EDT - 8 months ago

Prestige Consumer Healthcare Transcript: Barclays 18th Annual Global Consumer Staples Conference 2025

Sep 4, 2025, 7:00 AM EDT - 8 months ago

Prestige Consumer Healthcare to Present at the Barclays Global Consumer Staples Conference

2025-08-08T11:00:42.000Z - 9 months ago

Prestige Consumer price target lowered to $100 from $105 at Canaccord

Aug 7, 2025, 8:30 AM EDT - 9 months ago

Prestige Consumer Healthcare Earnings Call Transcript: Q1 2026

Aug 7, 2025, 6:00 AM EDT - 9 months ago

Prestige Consumer Healthcare Inc. Reports Fiscal 2026 First Quarter Results

Jul 15, 2025, 8:00 AM EDT - 10 months ago

Prestige Consumer Healthcare to Release Fiscal 2026 First Quarter Earnings Results

2025-06-17T21:45:08.000Z - 11 months ago

Medtech recalls Little Remedies Honey Cough Syrup due to contamination

Jun 17, 2025, 5:38 PM EDT - 11 months ago

Medtech Products Inc. Issues Nationwide Recall of Little Remedies® Honey Cough Syrup Due to Microbial Contamination

Jun 11, 2025, 10:30 AM EDT - 1 year ago

Prestige Consumer Healthcare Transcript: 25th Annual Consumer Growth and E-Commerce Conference

Jun 9, 2025, 4:30 PM EDT - 1 year ago

Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference

May 8, 2025, 8:30 AM EDT - 1 year ago

Prestige Consumer Healthcare Earnings Call Transcript: Q4 2025

May 8, 2025, 7:09 AM EDT - 1 year ago

UPDATED: Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings

May 8, 2025, 6:00 AM EDT - 1 year ago

Prestige Consumer Healthcare Inc. Reports Record Fiscal 2025 Revenue and Earnings

Apr 10, 2025, 5:00 PM EDT - 1 year ago

Prestige Consumer Healthcare to Release Fiscal 2025 Fourth Quarter and Year-End Earnings Results

Feb 6, 2025, 8:30 AM EST - 1 year ago

Prestige Consumer Healthcare Earnings Call Transcript: Q3 2025

Feb 6, 2025, 6:00 AM EST - 1 year ago

Prestige Consumer Healthcare Inc. Reports Record Third Quarter Results and Raises Full-Year Earnings Outlook

Jan 14, 2025, 11:30 AM EST - 1 year ago

Prestige Consumer Healthcare Transcript: 27th Annual ICR Conference 2025,

Nov 7, 2024, 8:30 AM EST - 1 year ago

Prestige Consumer Healthcare Earnings Call Transcript: Q2 2025

Sep 19, 2024, 10:45 AM EDT - 1 year ago

Prestige Consumer Healthcare Transcript: Sidoti September Small-Cap Virtual Conference

Sep 5, 2024, 2:15 PM EDT - 1 year ago

Prestige Consumer Healthcare Transcript: Barclays 17th Annual Global Consumer Staples Conference

Aug 8, 2024, 8:30 AM EDT - 1 year ago

Prestige Consumer Healthcare Earnings Call Transcript: Q1 2025

Aug 8, 2024, 6:00 AM EDT - 1 year ago

Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2025 Results

Jul 2, 2024, 4:30 PM EDT - 2 years ago

Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results

Jun 10, 2024, 1:30 PM EDT - 2 years ago

Prestige Consumer Healthcare Transcript: Oppenheimer's 24th Annual Virtual Consumer Growth and E-Commerce Conference

May 15, 2024, 8:30 AM EDT - 2 years ago

Prestige Consumer Healthcare Earnings Call Transcript: Q4 2024

May 14, 2024, 5:00 PM EDT - 2 years ago

Prestige Consumer Healthcare Inc. Reports Fiscal Year 2024 Results

Apr 25, 2024, 8:30 AM EDT - 2 years ago

Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results

Apr 3, 2024, 11:57 AM EDT - 2 years ago

Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag

Feb 8, 2024, 8:30 AM EST - 2 years ago

Prestige Consumer Healthcare Earnings Call Transcript: Q3 2024

Feb 8, 2024, 6:00 AM EST - 2 years ago

Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results

Feb 2, 2024, 9:00 AM EST - 2 years ago

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete's Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene

Jan 10, 2024, 5:00 PM EST - 2 years ago

Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results

Dec 22, 2023, 9:00 AM EST - 2 years ago

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine® 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene

Nov 24, 2023, 8:30 AM EST - 2 years ago

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray Powder Due to the Presence of Benzene

Nov 2, 2023, 8:30 AM EDT - 2 years ago

Prestige Consumer Healthcare Earnings Call Transcript: Q2 2024

Nov 2, 2023, 6:00 AM EDT - 2 years ago

Prestige Consumer Healthcare Inc. Reports Second Quarter Fiscal 2024 Results

Oct 5, 2023, 4:30 PM EDT - 2 years ago

Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Second Quarter Earnings Results

Sep 7, 2023, 3:00 PM EDT - 2 years ago

Prestige Consumer Healthcare Transcript: 2023 Barclays Global Consumer Staples Conference

Aug 3, 2023, 8:30 AM EDT - 3 years ago

Prestige Consumer Healthcare Earnings Call Transcript: Q1 2024

Aug 3, 2023, 6:00 AM EDT - 3 years ago

Prestige Consumer Healthcare Inc. Reports First Quarter Fiscal 2024 Results

Jul 11, 2023, 8:00 AM EDT - 3 years ago

Prestige Consumer Healthcare to Release Fiscal 2024 First Quarter Earnings Results

Jul 6, 2023, 4:30 PM EDT - 3 years ago

Prestige Consumer Healthcare Publishes Inaugural Sustainability Report

Jun 5, 2023, 9:00 AM EDT - 3 years ago

Prestige Consumer Healthcare to Present at Upcoming Investor Conferences

May 31, 2023, 9:00 AM EDT - 3 years ago

Goody's® Introduces New “GET TO GOOD™” Marketing Campaign

May 23, 2023, 2:00 PM EDT - 3 years ago

Dramamine® Eases Americans' Travel Woes with ‘Ditch the Drama' Sweepstakes Offering a Vacation to Anywhere in the World

May 4, 2023, 8:30 AM EDT - 3 years ago

Prestige Consumer Healthcare Earnings Call Transcript: Q4 2023

May 4, 2023, 6:00 AM EDT - 3 years ago

Prestige Consumer Healthcare Inc. Reports Record Fiscal Year 2023

Feb 2, 2023, 8:30 AM EST - 3 years ago

Prestige Consumer Healthcare Earnings Call Transcript: Q3 2023

Feb 2, 2023, 6:00 AM EST - 3 years ago

Prestige Consumer Healthcare Inc. Reports Third Quarter Results

Jan 5, 2023, 4:30 PM EST - 3 years ago

Prestige Consumer Healthcare Inc. to Release Fiscal 2023 Third Quarter Earnings Results

Nov 3, 2022, 8:30 AM EDT - 3 years ago

Prestige Consumer Healthcare Earnings Call Transcript: Q2 2023

Nov 3, 2022, 6:00 AM EDT - 3 years ago

Prestige Consumer Healthcare Inc. Reports Second Quarter Results and Reaffirms Outlook for Fiscal 2023

Oct 4, 2022, 4:30 PM EDT - 3 years ago

Prestige Consumer Healthcare Inc. to Release Fiscal 2023 Second Quarter Earnings Results

Sep 7, 2022, 5:03 PM EDT - 4 years ago

Prestige Consumer Healthcare to Present at Barclays Global Consumer Staples Investor Conference

Aug 4, 2022, 6:00 AM EDT - 4 years ago

Prestige Consumer Healthcare Inc. Reports Results for First Quarter Fiscal 2023

Aug 3, 2022, 8:56 PM EDT - 4 years ago

Prestige Consumer Healthcare Earnings Call Transcript: Q1 2023

Jul 11, 2022, 4:30 PM EDT - 4 years ago

Prestige Consumer Healthcare Inc. to Release Fiscal 2023 First Quarter Earnings Results

May 6, 2022, 8:13 AM EDT - 4 years ago

Prestige Consumer Healthcare Earnings Call Transcript: Q4 2022

May 5, 2022, 4:30 PM EDT - 4 years ago

Prestige Consumer Healthcare Inc. Reports Record Results for Fiscal 2022

Apr 14, 2022, 8:53 AM EDT - 4 years ago

Prestige Consumer Healthcare Inc. to Release Fiscal 2022 Fourth Quarter and Year-End Earnings Results

Feb 3, 2022, 2:46 PM EST - 4 years ago

Prestige Consumer Healthcare Earnings Call Transcript: Q3 2022

Feb 3, 2022, 6:00 AM EST - 4 years ago

Prestige Consumer Healthcare Inc. Reports Fiscal 2022 Third Quarter Results

Jan 10, 2022, 4:30 PM EST - 4 years ago

Prestige Consumer Healthcare Inc. to Release Fiscal 2022 Third Quarter Earnings Results

Nov 4, 2021, 6:00 AM EDT - 4 years ago

Prestige Consumer Healthcare Inc. Reports Fiscal 2022 Second Quarter Results

Oct 6, 2021, 4:30 PM EDT - 5 years ago

Prestige Consumer Healthcare Inc. to Release Fiscal 2022 Second Quarter Earnings Results

Aug 5, 2021, 6:00 AM EDT - 5 years ago

Prestige Consumer Healthcare Inc. Reports Fiscal 2022 First Quarter Results

StocktwitsEarnings May. 13 at 8:45 PM

0 · Reply

Estimize Apr. 28 at 1:00 PM

Wall St is expecting 1.39 EPS for $PBH Q4 [Reporting 04/30 BMO] http://www.estimize.com/intro/pbh?chart=historical&metric_name=eps&utm_cont

0 · Reply

Estimize Apr. 21 at 1:00 PM

Wall St is expecting 1.39 EPS for $PBH Q4 [Reporting 04/30 BMO] http://www.estimize.com/intro/pbh?chart=historical&metric_name=eps&utm_cont

0 · Reply

SuperGreenToday Apr. 7 at 2:19 AM

0 · Reply

PickAlpha Mar. 20 at 3:44 PM

0 · Reply

OfficialStocktwitsUser Mar. 11 at 4:05 AM

0 · Reply

ZacksResearch Feb. 12 at 3:20 PM

0 · Reply

ZacksResearch Feb. 12 at 2:20 PM

0 · Reply

briefingcom Feb. 5 at 1:39 PM

0 · Reply

StocktwitsEarnings Feb. 5 at 11:13 AM

$PBH Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $0.98 down -20.33% YoY • Reported revenue of $283.44M down -2.37% YoY

0 · Reply

MarginMonster Feb. 4 at 9:29 AM

$PBH prestige beauty, consumer resilience

0 · Reply

OfficialStocktwitsUser Jan. 16 at 3:19 AM

$PBH RSI: 66.91, MACD: 1.0240 Vol: 1.27, MA20: 63.08, MA50: 61.28 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

ZacksResearch Jan. 2 at 11:39 AM

Is now the moment to add $PBH to your portfolio — or wait it out? 🤔 Prestige Consumer Healthcare is riding e-commerce momentum, strategic acquisitions, and solid solvency, but inflation and tariff costs are creating near-term pressure investors can’t ignore. ⚠️ Get the full bull vs. risk breakdown here 👉 https://www.zacks.com/stock/news/2811195/is-this-the-right-time-to-add-pbh-stock-to-your-portfolio?cid=sm-stocktwits-2-2811195-teaser-27077&ADID=SYND_STOCKTWITS_TWEET_2_2811195_TEASER_27077

0 · Reply

BillionerOfKing Dec. 29 at 1:07 PM

$PBH Current Stock Price: $62.85 Contracts to trade: $65 PBH Jan 16 2026 Call Entry: $0.41 Exit: $0.78 ROI: 93% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

WebWave Dec. 26 at 6:21 AM

$PBH The thesis is evolving from vision-led to process-driven as scrutiny intensifies. Execution gaps should narrow meaningfully. Clear evidence of resilience would lower perceived risk. Patience is sensible — but only if matched by progress.

0 · Reply

BillionerOfKing Dec. 11 at 6:06 PM

$PBH Current Stock Price: $61.22 Contracts to trade: $60 PBH Jan 16 2026 Call Entry: $0.10 Exit: $0.17 ROI: 65% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

TimRegan_WTR Nov. 18 at 6:32 PM

$PBH

0 · Reply

JarvisFlow Nov. 7 at 9:57 PM

Canaccord Genuity has adjusted their stance on Prestige Consumer ( $PBH ), setting the rating to Buy with a target price of 100 → 88.

0 · Reply

BillionerOfKing Nov. 7 at 2:14 PM

$PBH Current Stock Price: $61.40 Contracts to trade: $60 PBH Nov 21 2025 Call Entry: $3.54 Exit: $6.53 ROI: 85% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Estimize Nov. 6 at 11:00 AM

$PBH reported - EPS and - revenue for Q2. http://www.estimize.com/intro/pbh?chart=historical&metric_name=eps&utm_content=PBH&utm_medium=act

0 · Reply

Market Cap	2.40B
Revenue (ttm)	1.14B
Net Income (ttm)	214.61M
EPS (ttm)	N/A
PE Ratio	11.73
Forward PE	11.01
Profit Margin	18.86%
Debt to Equity Ratio	0.56

Volume	749,860
Avg Vol	536,062
Day's Range	N/A - N/A
Shares Out	47.32M
Stochastic %K	15%
Beta	0.40
Analysts	Strong Sell
Price Target	$72.33